BCG Unresponsive NMIBC Market to Register Sustainable Growth During the Study Period (2020-2034) | DelveInsight [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
CG Oncology, Inc. (CGON)
Company Research
Source: Yahoo! Finance
market launch of photodynamic therapy and non-viral gene therapy, and raised awareness. LAS VEGAS July 3, 2024 /PRNewswire/ -- DelveInsight's BCG Unresponsive NMIBC Market Insights report includes a comprehensive understanding of current treatment practices, BCG unresponsive NMIBC emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [ the United States , the EU4 ( Germany France Italy , and Spain ) and the United Kingdom , and Japan ]. Key Takeaways from the BCG Unresponsive NMIBC Market Report According to DelveInsight's analysis, the market size for BCG unresponsive NMIBCs is expected to grow significantly by 2034. 30% to 50% of cases involving non-muscle-invasive bladder cancer (NMIBC) do not respond to Bacillus Calmette-Guérin (BCG) treatment. Leading BCG unresponsive NMIBC companies such as Johnson & Johnson, enGene , and others are developing novel BCG unresponsive NMIBC drugs that can be ava
Show less
Read more
Impact Snapshot
Event Time:
CGON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CGON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CGON alerts
High impacting CG Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
CGON
News
- Alumis raises $250m in IPO as biotech stock stirs [Yahoo! Finance]Yahoo! Finance
- CG Oncology, Inc. (NASDAQ: CGON) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $65.00 price target on the stock.MarketBeat
- Zenas BioPharma Weighs $150 Million-Plus IPO as Soon as July [Yahoo! Finance]Yahoo! Finance
- Zenas BioPharma Weighs $150 Million-Plus IPO as Soon as July [BNN Bloomberg (Canada)]BNN Bloomberg
- This year's IPO market got off to a roaring start. Now some fear it's out of gas [Yahoo! Finance]Yahoo! Finance
CGON
Sec Filings
- 5/24/24 - Form 8-K
- 5/16/24 - Form 4
- 5/16/24 - Form 3
- CGON's page on the SEC website